Evolus price target raised to $17 from $15 at Mizuho

Mizuho analyst Uy Ear raised the firm’s price target on Evolus to $17 from $15 and keeps a Buy rating on the shares following the company’s report of "solid" preliminary Q4 revenues and an "optimistic" outlook. Both the 2023 and the 2028 outlook could be conservative and could see upside, the analyst argues.